VTEval Project - Three Observational, Prospective Cohort Studies Including Biobanking to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in Venous Thromboembolism

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Venous thromboembolism (VTE) with its two clinical manifestations deep vein thrombosis (DVT) and pulmonary embolism (PE) is a life-threatening disease that is associated with considerable morbidity and mortality. The incidence of VTE increases with age and it - as the third most common cardiovascular disease after ischemic heart disease and stroke - represents an important public health problem in industrialized countries with several aspects in need to be addressed. VTEval Project includes three long-term prospective observational studies to evaluate and improve VTE diagnostics and management, treatment and outcome. The aims of the project include a systematic assessment of VTE, i.e. disease status (symptoms, clinical and subclinical aspects) and risk profiles (classic, psychosocial and environmental factors), using a system-oriented approach. VTEval collects three large prospective cohorts of patients with suspected and incident VTE consisting of individuals with a clinical suspicion of acute PE, individuals with a clinical suspicion of acute DVT, and individuals with incidental diagnosis of VTE). The standardized and harmonized data acquisition of the study establishes a sustainable resource for comprehensive research on VTE, thus providing the basis for both short- and long-term analysis.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age ≥18 years and Informed written consent

• Clinical condition:

‣ Cohort 1: Clinical suspicion of acute PE (with or without DVT)

⁃ Cohort 2: Clinical suspicion of acute DVT (without symptomatic PE)

⁃ Cohort 3: Incidentally diagnosed VTE

Locations
Other Locations
Germany
University Medical Center of the Johannes Gutenberg University Mainz
RECRUITING
Mainz
Contact Information
Primary
Philipp S Wild, MD, MSc
philipp.wild@unimedizin-mainz.de
0049 6131 17 7163
Time Frame
Start Date: 2013-04
Estimated Completion Date: 2030-07
Participants
Target number of participants: 2000
Treatments
Cohort 1: Suspect of Pulmonary Embolism (PE)
Cohort 2: Suspect of Deep Vein Thrombosis (DVT)
Cohort 3: Incidental Venous Thromboembolism (VTE)
Sponsors
Collaborators: Hochschule Fresenius, Siemens Corporation, Corporate Technology, Bayer, University of Bonn, Maastricht University, Eurofins
Leads: Johannes Gutenberg University Mainz

This content was sourced from clinicaltrials.gov